Relyvrio ALS Drug Withdrawn by Manufacturer Due to Lack of Efficacy Due to FDA concerns about its efficacy, Relyvrio, an ALS medication, was removed from the market by Amylyx Pharmaceuticals. by Quincy Jon
Health Elon Musk's Neuralink Launches PRIME Study: First Human Clinical Trials for Brain-Computer Interface Starting Soon by Quincy Jon
Tech iPhone 14 Repairs Are Easier, But Apple's Strict 'Parts Pairing' Policy May Upset You by Trisha Kae Andrada
Health Move Over Neuralink, This 'Stentrode' Brain Chip Lets Paralyzed Patients Control Computers with Their Minds! by Isaiah Alonzo
Health Brain Implant Helps Paralyzed ALS Patient Communicate With Caregivers Without Assistance by Rhodi Lee
Healthy Living/Wellness Steve Gleason Bill Passes House: Landmark Victory For ALS Patients by Jill Arce
Healthy Living/Wellness Funeral Directors Face Higher Risks Of ALS Due To Formaldehyde Use by Jill Arce
Culture Stephen Hawking: Zayn Malik Might Still Be With One Direction In Parallel Universe by Menchie Mendoza
Business Tech Newly Minted Biotech Firm to Tackle Parkinson's Disease, Alzheimer's and ALS by Sumit Passary
Healthy Living/Wellness Blood pressure medication can lower ALS risk: First drug treatment for illness? by James Maynard
Healthy Living/Wellness Intel, Stephen Hawking showcase Connected Wheelchair Project by Menchie Mendoza
Science ‘Theory of Everything’ looks like everything a Stephen Hawking biopic should be by Rebecca Kaplan
Culture Foo Fighters frontman Dave Grohl reenacts 'Carrie' scene in Ice Bucket Challenge for ALS by Jarrett Kruse
Healthy Living/Wellness Ice bucket challenge for ALS blazes on social media, the numbers so far by Menchie Mendoza
Healthy Living/Wellness Transforming thought into action: Accenture, Philips announce wearable tech for neurodegenerative patients by Linda Nguyen